Olof Dahlqvist Leinhard
Chief Executive Officer & Founder AMRA Medical
Seminars
Wednesday 1st October 2025
MRI-based Body Composition Reimagined: Building a New Foundation for Treatment Differentiation Beyond Weight Loss
11:30 am
- FDA-cleared MRI-based body composition analysis provides a new standard for muscle and fat quantification enabling translation from population studies and clinical trials all the way into healthcare.
- Studies on Personalized Fat and Muscle Z-score biomarkers show improved prediction of outcomes and that weight- and BMI-invariant treatment effects can be detected.
- Understanding loss of muscle mass and shifts in fat distribution in the context of weight reduction and exploring the varying effects of liraglutide and tirzepatide in recent clinical trials.
